Back
BioCryst Pharmaceuticals Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.23
Seasonality Move:
-9.69%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.BioCryst Pharmaceuticals Price Quote
$8.23
+0.26 (+3.26%)
(Updated: September 19, 2024 at 12:35 PM ET)
BioCryst Pharmaceuticals Key Stats
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Day range:
$7.91 - $8.25
52-week range:
$4.03 - $8.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.19
P/B ratio:
0%
Volume:
1.7M
Avg. volume:
1.8M
1-year change:
5.84%
Market cap:
$1.6B
Revenue:
$331.4M
EPS:
$-0.73
How Much Does BioCryst Pharmaceuticals Make?
-
How Much Are BioCryst Pharmaceuticals's Sales Annually?
BCRX Revenues are $331.4M -
How Much Profit Does BioCryst Pharmaceuticals's Make A Year?
BCRX net income is -$226.5M
Is BioCryst Pharmaceuticals Growing As A Company?
-
What Is BioCryst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.33% -
What Is BioCryst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioCryst Pharmaceuticals Stock Price Performance
-
Did BioCryst Pharmaceuticals Stock Go Up Last Month?
BioCryst Pharmaceuticals share price went up by 4.32% last month -
Did BCRX's Share Price Rise Over The Last Year?
BCRX share price rose by 5.84% over the past 1 year
What Is BioCryst Pharmaceuticals 52-Week High & Low?
-
What Is BioCryst Pharmaceuticals’s 52-Week High Share Price?
BioCryst Pharmaceuticals has traded as high as $8.88 over the past 52 weeks -
What Is BioCryst Pharmaceuticals’s 52-Week Low Share Price?
BioCryst Pharmaceuticals has traded as low as $4.03 over the past 52 weeks
BioCryst Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioCryst Pharmaceuticals?
-
How Much Debt Does BioCryst Pharmaceuticals Have?
Total long term debt quarterly is $808.5M -
How Much Cash Does BioCryst Pharmaceuticals Have?
Cash and short term investments quarterly total is $272M -
What Is BioCryst Pharmaceuticals’s Book Value Per Share?
Book value per share is -2.30
Is BioCryst Pharmaceuticals Cash Flow Positive?
-
What Is BCRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$83.9M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $21M
BioCryst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
BCRX return on invested capital is -38.85% -
What Is BioCryst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -29.07% -
What Is BCRX Return On Equity?
ROE is a measure of profitability and is 0%
BioCryst Pharmaceuticals Earnings Date & Stock Price
-
What Is BioCryst Pharmaceuticals's Stock Price Today?
A single share of BCRX can be purchased today for 7.97 -
What Is BioCryst Pharmaceuticals’s Stock Symbol?
BioCryst Pharmaceuticals trades on the nasdaq under the ticker symbol: BCRX -
When Is BioCryst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for BioCryst Pharmaceuticals is scheduled on November 1, 2024 -
When Is BCRX's next ex-dividend date?
BioCryst Pharmaceuticals's next ex-dividend date is September 19, 2024 -
How To Buy BioCryst Pharmaceuticals Stock?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioCryst Pharmaceuticals Competitors
-
Who Are BioCryst Pharmaceuticals's Competitors?
Below is a list of companies who compete with BioCryst Pharmaceuticals or are related in some way:
BioCryst Pharmaceuticals Dividend Yield
-
What Is BCRX Dividend Yield?
BioCryst Pharmaceuticals’s dividend yield currently is 0% -
What Is BioCryst Pharmaceuticals’s Payout Ratio?
BioCryst Pharmaceuticals’s payout ratio is 0% -
When Did BioCryst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is BioCryst Pharmaceuticals’s Dividend Per Share?
BioCryst Pharmaceuticals pays a dividend of $0.00 per share
BioCryst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 63.28% |
| Revenue: | 32.54% | 11.2% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 13.90 |
| Upside from Last Price: | 74.4% |